Shortening antibiotic courses for common throat and chest infections in primary care with doctor–pharmacist teamwork and viral‑circulation updates

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cluster-randomized trial conducted in six primary care practices (24 physicians) affiliated with CHU Caen Normandie, with three practices randomized to a bimodal intervention and three to usual care. The intervention combines regular communication about the circulation of respiratory viruses and a multidisciplinary GP–pharmacist protocol to verify that prescribed antibiotic durations follow guidelines. The primary aim is to see if this package reduces the duration of antibiotic treatments for upper and lower respiratory tract infections. Eligible encounters include a wide range of acute respiratory diagnoses, and patients under legal protection are excluded.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- Patient seen in consultation for an upper or lower respiratory tract infection (Angina, Acute bronchiolitis, Acute bronchitis, COPD exacerbation (AECOPD), Laryngitis, Acute otitis media (AOM), Serous or congestive otitis, Viral respiratory infection (e.g., influenza), Community-acquired pneumonia (CAP), Rhinitis / Nasopharyngitis, Acute sinusitis)

Exclusion Criteria:

\- Patient under legal protection

Where it's running

• CHU CAEN Normandie
  Caen, France Recruiting

Study contacts

• Study coordinator: Renaud Verdon, PU-PH
• Email: verdon-r@chu-caen.fr
• Phone: +33231064709

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chest X-ray vs ultra-low-dose chest CT in adults with possible pneumonia in the ER

  This study tests whether an ultra-low-dose chest CT can replace chest X-ray for adults in the emergency department when pneumonia is a possibility, to see if it changes how much staff time is spent on imaging.

  Recruiting University of Southern Denmark · Aabenraa · NCT07870525

• Montelukast for acute bronchiolitis in infants and young children

  This study tests whether adding montelukast to standard care helps shorten hospital stays and relieve symptoms in indoor patients aged 4 weeks to 2 years with acute bronchiolitis.

  Recruiting Phase 2 Pakistan Institute of Medical Sciences · Islamabad, Federal · NCT07770464

• Which antibiotic works best for kids with sinus infections?

  This study tests whether amoxicillin, amoxicillin-clavulanate, or a placebo help children with acute sinusitis feel better faster.

  Recruiting Phase 4 University of Pittsburgh · Denver, Colorado and 4 other locations · NCT07732699

• Comparing Antibiotics and Placebo for Ear Infections in Toddlers

  This trial tests whether amoxicillin, amoxicillin-clavulanate, or a placebo help reduce symptoms in children with acute otitis media.

  Recruiting Phase 4 University of Pittsburgh · Denver, Colorado and 4 other locations · NCT07730814

• Lefamulin Post-Market Surveillance in Community-Acquired Pneumonia

  This study follows people with community-acquired pneumonia who are being treated with lefamulin to see how it works in real-world clinical use.

  Recruiting Marubeni Pharmaceuticals (Suzhou) Co., Ltd. · Beijing, Beijing Municipality · NCT07697885

• Raphamin for acute bronchitis in adults

  This study tests whether Raphamin helps adults with acute bronchitis feel better faster compared with a placebo.

  Recruiting at 29 sites Phase 3 Materia Medica Holding · Aramil and 32 other locations · NCT07650227

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.